HEALTH
Allergan to Sell Unit: Allergan Inc. said it had agreed to sell its diagnostic instrument subsidiary, Allergan Humphrey, to the German-based Carl Zeiss for an undisclosed price. Analysts valued the sale at between $50 million and $70 million. Sales at Allergan Humphrey have been declining since 1988, and although Allergan said the unit was not losing money, profit margins were slim. The Irvine-based company said it would use proceeds from the sale to reduce debt and strengthen its core businesses of developing pharmaceutical and consumer products for eye and skin care.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.